Shanghai Hutchison Pharmaceuticals Limited

This large, late-stage study is testing whether a new intravenous medicine called SHPL-49 can help people recover better after an acute ischemic stroke. About 1,100 participants who have recently had a stroke will receive either the study medicine or a placebo infusion for 7 days…